Norwegian Spontaneous Coronary Artery Dissection Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOslo University Hospital

About this trial

The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospitalized with SCAD are recruited during the index hospitalization. Each participant will be followed for 52 weeks with scheduled visits at 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac assessments, genetic analyses, blood sampling, structured questionnaires, and a cardiopulmonary exercise test (CPET).

Eligibility criteria

Qualifiers

Spontaneous coronary artery dissection

Disqualifiers

Severe kidney failure

Severe allergic reaction to contrast

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

300 Participants
are grouped into 1 trial group

Sponsors and collaborators

Oslo University Hospital

Lead sponsor

University Hospital, Akershus

Collaborator

Haukeland University Hospital, Bergen, Norway

Collaborator

Sorlandet Hospital HF

Collaborator

Universitetssykehuset i Nord-Norge HF

Collaborator

Ullevaal University Hospital

Collaborator

Helse Stavanger HF

Collaborator

St. Olavs Hospital

Collaborator